Difference between revisions of "WSI21-139-Case-1"

From MGH Learn Pathology
(Automatic edit to upgrade to new templates)
(Added status template)
 
(6 intermediate revisions by 3 users not shown)
Line 1: Line 1:
 
{{ServiceRequestCase
 
{{ServiceRequestCase
|identifier=WSI21-139-Case-1
+
|requisition=Cytology
 +
|subject=MGH
 
|intent=order
 
|intent=order
 
|category=409073007
 
|category=409073007
 +
|basedOn=WSI21-139
 
|priority=routine
 
|priority=routine
 +
|code=study
 
|orderDetail=case
 
|orderDetail=case
|locationCode=learn
 
|basedOn=WSI21-139
 
|code=study
 
|requisition=Cytology
 
|supportingInfo=Metastatic papillary thyroid carcinoma.
 
|reasonCode=82F. Right neck lymphadenopathy. Level IV lymph node FNA.
 
|subject=public
 
|performer=Iac0
 
 
|authoredOn=November 30, 2021 05:36:01 PM
 
|authoredOn=November 30, 2021 05:36:01 PM
 
|requester=Iac0
 
|requester=Iac0
 +
|locationCode=learn
 
|sequence=1
 
|sequence=1
 +
|performer=IAC0
 +
|reasonCode=82F. Right neck lymphadenopathy. Level IV lymph node FNA.
 +
|supportingInfo=Metastatic papillary thyroid carcinoma.
 +
|identifier=WSI21-139-Case-1
 +
|access=public
 
}}
 
}}
 
{{Media
 
{{Media
|basedOn=WSI21-139-Case-1
+
|createdDateTime=November 30, 2021 05:36:01 PM
 +
|operator=Iac0
 +
|frames=1
 
|type=image
 
|type=image
 +
|subject=N21-10600_1_9_1
 +
|reasonCode=Papanicolaou
 
|view=show
 
|view=show
|partOf=WSI21-139
+
|modality=mrxs
|frames=1
 
|reasonCode=Papanicolaou
 
|identifier=WSI21-139-Case-1_1
 
|createdDateTime=November 30, 2021 05:36:01 PM
 
|operator=Iac0
 
|subject=Z0FBQUFBQmhwbUZ6SENnZk9tV1dvRGcwSFlmVVdZME9PcnVsSU9KWFlxM0ZSRTRaYjhtU2stcVd5TDNDNUN1d3NpUkwzdk1pOUJXTGpnUkJLNVJ0VjBkNkdEcnp5Q3AxZ0E9PQ
 
|modality=None
 
 
}}
 
}}
 
{{Media
 
{{Media
|basedOn=WSI21-139-Case-1
 
|type=image
 
|view=show
 
|partOf=WSI21-139
 
|frames=2
 
|reasonCode=Papanicolaou
 
|identifier=WSI21-139-Case-1_2
 
 
|createdDateTime=November 30, 2021 05:36:01 PM
 
|createdDateTime=November 30, 2021 05:36:01 PM
 
|operator=Iac0
 
|operator=Iac0
 +
|frames=2
 +
|type=image
 
|subject=Z0FBQUFBQmhwbUZfOENya2RkbHlFOURETU5qN3gwbWhSSWtqRVhfamdvNGtBQU12UE9WVE5Mbk1yeEtLRU9Qd1c4eUt3TWd6YWt6c0lDRFZzaENmN3ZQN0M4UjlfRFFtSUE9PQ
 
|subject=Z0FBQUFBQmhwbUZfOENya2RkbHlFOURETU5qN3gwbWhSSWtqRVhfamdvNGtBQU12UE9WVE5Mbk1yeEtLRU9Qd1c4eUt3TWd6YWt6c0lDRFZzaENmN3ZQN0M4UjlfRFFtSUE9PQ
|modality=None
+
|reasonCode=Papanicolaou
 +
|view=show
 +
|modality=mrxs
 
}}
 
}}
 
{{Media
 
{{Media
|basedOn=WSI21-139-Case-1
 
|type=image
 
|view=show
 
|partOf=WSI21-139
 
|frames=3
 
|reasonCode=H&E
 
|identifier=WSI21-139-Case-1_3
 
 
|createdDateTime=November 30, 2021 05:36:01 PM
 
|createdDateTime=November 30, 2021 05:36:01 PM
 
|operator=Iac0
 
|operator=Iac0
 +
|frames=3
 +
|type=image
 
|subject=Z0FBQUFBQmhwbUdNV0lnb3phYWZ2TFBWRXVJZVU4eUZmV1pMWUZac2FQUjNwMWYtUS05Q0l0VnFvUnBlWFlvSU56Zl91SmYzVWtBSFdSNXFJaWFPWHRvSmsyYkRka2twaGd4bHMyNFUzWktHM3N6ZTZydU9TOWc9
 
|subject=Z0FBQUFBQmhwbUdNV0lnb3phYWZ2TFBWRXVJZVU4eUZmV1pMWUZac2FQUjNwMWYtUS05Q0l0VnFvUnBlWFlvSU56Zl91SmYzVWtBSFdSNXFJaWFPWHRvSmsyYkRka2twaGd4bHMyNFUzWktHM3N6ZTZydU9TOWc9
|modality=None
+
|reasonCode=H&E
 +
|view=show
 +
|modality=mrxs
 
}}
 
}}
 
{{Media
 
{{Media
|basedOn=WSI21-139-Case-1
 
|type=image
 
|view=show
 
|partOf=WSI21-139
 
|frames=4
 
|reasonCode=TTF1
 
|identifier=WSI21-139-Case-1_4
 
 
|createdDateTime=November 30, 2021 05:36:01 PM
 
|createdDateTime=November 30, 2021 05:36:01 PM
 
|operator=Iac0
 
|operator=Iac0
 +
|frames=4
 +
|type=image
 
|subject=Z0FBQUFBQmhwbUd0SjQ3TkVQQkdKaTlITHBwcGJtb3hxUVoxZEVsQzdHQk1na3pSd0RuUFQxalpkaEM4cWVxc21UdDktMEl4bk9lRHZQU0JIYjluUHY5ZEVldzd5V0dSc1Nnb2J0Q3dPUHBLSlVZU3NaWmFJSmM9
 
|subject=Z0FBQUFBQmhwbUd0SjQ3TkVQQkdKaTlITHBwcGJtb3hxUVoxZEVsQzdHQk1na3pSd0RuUFQxalpkaEM4cWVxc21UdDktMEl4bk9lRHZQU0JIYjluUHY5ZEVldzd5V0dSc1Nnb2J0Q3dPUHBLSlVZU3NaWmFJSmM9
|modality=None
+
|reasonCode=TTF1 (thyriod transcription factor 1)
 +
|view=show
 +
|modality=mrxs
 
}}
 
}}
 
{{Media
 
{{Media
|basedOn=WSI21-139-Case-1
 
|type=image
 
|view=show
 
|partOf=WSI21-139
 
|frames=5
 
|reasonCode=PAX8
 
|identifier=WSI21-139-Case-1_5
 
 
|createdDateTime=November 30, 2021 05:36:01 PM
 
|createdDateTime=November 30, 2021 05:36:01 PM
 
|operator=Iac0
 
|operator=Iac0
 +
|frames=5
 +
|type=image
 
|subject=Z0FBQUFBQmhwbUc4NnBlYV90Q1V1RGxQeEg4c3pGUnVaRW41TnRhckxsUm1YVGstX3Y0c1NVbXU5RkJPSU9qVUZ5LTlmUnQxYzlRQzBLUW9uTWQ0aFNCY19uTGttWE96Nk5ER2dNWm9DTXlfbk10RXZFVXZjV1U9
 
|subject=Z0FBQUFBQmhwbUc4NnBlYV90Q1V1RGxQeEg4c3pGUnVaRW41TnRhckxsUm1YVGstX3Y0c1NVbXU5RkJPSU9qVUZ5LTlmUnQxYzlRQzBLUW9uTWQ0aFNCY19uTGttWE96Nk5ER2dNWm9DTXlfbk10RXZFVXZjV1U9
|modality=None
+
|reasonCode=PAX8
 +
|view=show
 +
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Iac0
 +
|authoredOn=November 30, 2021 05:36:01 PM
 
}}
 
}}

Latest revision as of 14:10, December 9, 2024

WSI21-139-Case-1
82F. Right neck lymphadenopathy. Level IV lymph node FNA.
Metastatic papillary thyroid carcinoma.
No results